Skip to main content
. 2020 Mar 27;40(3):BSR20200352. doi: 10.1042/BSR20200352

Table 1. The relationships between SII and clinicopathological variables.

Variables Cases Preoperative SII x2 P-value
Low High
Sex 19.667 <0.001*
  Male 343 103 (30.0%) 240 (70.0%)
  Female 195 96 (49.2%) 99 (50.8%)
Age (years) 0.646 0.422
  ≤60 269 95 (35.3%) 174 (64.7%)
  >60 269 104 (38.7%) 165 (61.3%)
Smoking history 5.183 0.023*
  Yes 344 115 (33.4%) 229 (66.6%)
  None 194 84 (43.3%) 110 (56.7%)
Histological type 22.293 <0.001*
  SqCC 254 70 (27.6%) 184 (72.4%)
  Adenocarcinoma 216 105 (48.6%) 111 (51.4%)
  Others 68 24 (35.3%) 44 (64.7%)
Tumor location 0.406 0.524
  Left 223 86 (38.6%) 137 (61.4%)
  Right 315 113 (35.9%) 202 (64.1%)
Lesion type 12.617 <0.001*
  Peripheral 378 158 (41.8%) 220 (58.2%)
  Central 160 41 (25.6%) 119 (74.4%)
Resection type 18.269 <0.001*
  Lobectomy 460 187 (40.7%) 273 (59.3%)
  Pneumonectomy 78 12 (15.4%) 66 (84.6%)
Lymph node metastasis 1.217 0.270
  No 297 116 (39.1%) 181 (60.9%)
  Yes 241 83 (34.4%) 158 (65.6%)
Pathological stage 20.561 <0.001*
  I 230 107 (46.5%) 123 (53.5%)
  II 114 25 (21.9%) 89 (78.1%)
  IIIA 194 67 (34.5%) 127 (65.5%)
NLR 92.833 <0.001*
  Low 319 171 (53.6%) 148 (46.4%)
  High 219 28 (12.8%) 191 (87.2%)
PLR 68.609 <0.001*
  Low 351 174 (49.6%) 177 (50.4%)
  High 187 25 (13.4%) 162 (86.6%)
LMR 73.343 <0.001*
  High 287 154 (53.7%) 133 (46.3%)
  Low 251 45 (17.9%) 206 (82.1%)
Fibrinogen 44.506 <0.001*
  Low 256 132 (51.6%) 124 (48.4%)
  High 282 67 (23.8%) 215 (76.2%)
Bone metastasis 7.299 0.007*
  None 479 282 (48.5%) 299 (51.5%)
  Yes 57 17 (29.8%) 40 (70.2%)
*

Was considered to be statistically significant.